Why in news
The rise of drug-resistant fungal infections, notably Trichophyton indotineae, is emerging as a significant health concern in India.
This resilient dermatophyte, linked to the misuse of topical steroids, poses challenges for both patients and healthcare providers
What is Trichophyton indotineae
Trichophyton indotineae is a newly identified dermatophyte, a type of fungus causing skin infections.
It was first described in 2019 through genetic sequencing, identifying it as genotype VIII within the T. mentagrophytes/T. interdigitale species complex.
Initially identified in India, this fungus has spread to several other countries and is noted for its significant presence in the Indian subcontinent.
Clinical Impact
Causes persistent, inflammatory, and itchy skin infections, often affecting the groin, gluteal region, trunk, and face.
Symptoms include red, scaly, and itchy rashes
Shows resistance to common antifungal medications like terbinafine and itraconazole due to genetic mutations.
Treatment can be complicated by side effects and suboptimal drug quality, particularly with itraconazole.
Challenges
Misdiagnosis and ineffective treatments contribute to prolonged and worsened infections
Resistance to topical steroid creams used improperly exacerbates the issue.
Treatment and Care
Effective treatment often involves antifungal medications, skin care regimens, and proper hygiene practices to support healing and prevent recurrence.
Prevention
Emphasizes good hygiene, keeping skin dry, avoiding sharing personal items, and wearing breathable clothing.
Regular washing and maintaining a healthy lifestyle support prevention and recovery.
COMMENTS